Today's Hours: 8:00am - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya.
    Contents:
    Intro
    Preface
    Abstract
    Acknowledgment
    Contents
    About the Authors
    Abbreviations
    Part I
    Chapter 1: Ocular Pharmacokinetics
    References
    Chapter 2: Factors Affecting Bioavailability and Efficacy of Topical Ophthalmic Preparations
    References
    Chapter 3: Ideal Characteristics of Ophthalmic Drug Delivery System
    References
    Chapter 4: Inactive Ingredients Used in the Preparation of Ophthalmic Products
    References
    Chapter 5: Preservatives Used in Ophthalmic Preparations
    Reference
    Part II
    Chapter 6: Topical Ophthalmic Drug Forms
    References Chapter 7: Extemporaneous Compounding of Ophthalmic Products
    Reference
    Chapter 8: Guidelines of The American Society of Health-System Pharmacists (ASHP) on Pharmacy-Prepared Ophthalmic Products
    Reference
    Chapter 9: Formulations of Extemporaneous Topical Ophthalmic Preparations
    9.1 Acetylcysteine Ophthalmic Solution [1-4]
    9.2 Amikacin Ophthalmic Solution [5, 6]
    9.3 Amphotericin B Ophthalmic Solution [7-12]
    9.4 Atropine Ophthalmic Solution [13-15]
    9.5 Autologous Serum Ophthalmic Solution [16-22]
    9.6 Bacitracin Ophthalmic Solution [15, 23] 9.7 Cefazolin Sodium Ophthalmic Solution [15, 24-29]
    9.8 Ceftazidime Ophthalmic Solution [15, 24, 30-33]
    9.9 Cefuroxime Ophthalmic Solution [15, 34, 35]
    9.10 Ceftriaxone Ophthalmic Solution [36, 37]
    9.11 Clindamycin Ophthalmic Solution [38]
    9.12 Cyclosporine Ophthalmic Solution [39-49]
    9.13 Colistimetate Ophthalmic Solution [50-54]
    9.14 Edetate Disodium Ophthalmic Solution [15, 55-58]
    9.15 5-Fluorouracil Ophthalmic Solution [59-65]
    9.16 Gentamicin Ophthalmic Solution [38, 66, 67]
    9.17 Interferon Alfa-2b Ophthalmic Solution [68-80] 9.18 Medroxyprogesterone Ophthalmic Solution [81-83]
    9.19 Mitomycin-C Ophthalmic Solution [84-100]
    9.20 Penicillin G Potassium Ophthalmic Solution [84, 85, 101]
    9.21 Tacrolimus Ophthalmic Solution [102, 103]
    9.22 Tobramycin Ophthalmic Solution [84, 85, 104]
    9.23 Vancomycin Hydrochloride Ophthalmic Solution [38, 105-107]
    9.24 Voriconazole Ophthalmic Solution [108-118]
    References
    Part III
    Chapter 10: Intravitreal Injections
    References
    Chapter 11: Intracameral Injections
    Reference
    Chapter 12: Formulations of Extemporaneous Intraocular Injections 12.1 Amikacin Sulfate Intravitreal Injection [1]
    12.2 Amphotericin B Intravitreal Injection [2-6]
    12.3 Bevacizumab Intravitreal Injection [7-12]
    12.4 Cefazolin Sodium Intravitreal Injection [3, 13]
    12.5 Ceftazidime Intravitreal Injection [3, 13, 14]
    12.6 Cefuroxime Intracameral Injection [15]
    12.7 Cidofovir Intravitreal Solution [16]
    12.8 Clindamycin Intravitreal Injection [17-20]
    12.9 Dexamethasone Phosphate Intravitreal Injection [21]
    12.10 Foscarnet Intravitreal Injection [22-24]
    12.11 Ganciclovir Intravitreal Injection [22, 25, 26]
    12.12 Penicillin G Potassium Intravitreal Injection [27-29]
    Digital Access Springer 2020